Characteristics (Mean ± SD) | Control (n = 34) | MSA-D (n = 32) | MSA-ND (n = 30) | F/χ2 | P-value |
---|---|---|---|---|---|
Age (years) | 63.97 ± 5.08 | 63.03 ± 5.94 | 64.70 ± 7.74 | 0.55 | 0.58 |
Gender (male: female) | 20:24 | 16:16 | 16:14 | 0.26 | 0.77 |
Education | 11.44 ± 3.11 | 11.00 ± 4.31 | 11.27 ± 3.61 | 0.12 | 0.89 |
Disease duration | N | 3.17 ± 1.63 | 3.57 ± 1.83 | 0.48 | 0.49 |
UMSARS score | N | 33.22 ± 17.47 | 28.05 ± 18.63 | 0.05 | 0.83 |
Hoehn and Yahr | N | 2.53 ± 1.09 | 2.37 ± 1.16 | 0.14 | 0.71 |
LEDD (mg/day) | N | 335.94 ± 292.10 | 330.00 ± 354.31 | 0.94 | 0.17 |
Clinical phenotype (P/C) | N | 15:17 | 13:17 | 0.28 | 0.60 |
MMSE score | 28.78 ± 1.35 | 28.00 ± 1.78 | 28.40 ± 1.04 | 2.37 | 0.58 |
HAMD-24 score | 1.5 ± 1.81 | 20.00 ± 6.25 | 4.80 ± 2.44 | 196.59 | 0.00* |
HAMA-14 score | 1.15 ± 1.10 | 3.44 ± 1.52 | 3.23 ± 1.71 | 24.98 | 0.00* |
Dopamine agonists | N | 20.16 ± 35.01 | 33.33 ± 76.38 | 2.61 | 0.11 |